首页 > 最新文献

Pediatrics International最新文献

英文 中文
Perspectives on childhood coronavirus disease vaccination in Japan and influencing factors. 日本儿童冠状病毒病疫苗接种情况及影响因素。
IF 1 4区 医学 Q3 PEDIATRICS Pub Date : 2024-01-01 DOI: 10.1111/ped.15819
Madoka Lelliott, Masatsugu Sakata, Ayako Kohno, Rie Toyomoto, Ayuko Matsumoto, Toshi A Furukawa

Background: To support parental decision-making it is important to understand parents' perspectives on vaccination for their children and the factors that contribute to their vaccine hesitancy. There have been relatively few studies in this area in Japan, particularly with longitudinal and mixed methodologies.

Methods: We used an explanatory sequential mixed methods approach to describe longitudinal changes in vaccine acceptance and to explore factors associated with parental coronavirus 2019 (COVID-19) vaccine hesitancy. We recruited parents who had children aged 6 months to 11 years old from five facilities in Japan. Two cross-sectional online surveys and semi-structured online interviews were conducted. Logistic regression analysis was used to explore factors associated with parents' vaccine hesitancy for their children, and thematic analysis was used to analyze the interview data.

Results: In total, 134 parents responded to both online surveys and, of those, 10 participated in interviews. Acceptance rates of COVID-19 vaccination for their children were 19.4% (26/134) at the first survey and 11.2% (15/134) at the second survey. Integration of the data identified that the main factors for vaccine hesitancy included vaccine safety, vaccine effectiveness, government policy, and recommendations from people close to parents.

Conclusions: Readily available and more balanced information, and community-wide support from people close to parents and familiar health-care providers are likely to provide better support for parents' decision-making. Further investigation is required on how to provide information in an easily understood manner.

背景:为了支持家长的决策,了解家长对子女接种疫苗的看法以及导致他们对疫苗犹豫不决的因素非常重要。在日本,这方面的研究相对较少,尤其是采用纵向和混合方法的研究:我们采用了一种解释性顺序混合方法来描述疫苗接受度的纵向变化,并探讨与父母对 2019 年冠状病毒(COVID-19)疫苗犹豫不决有关的因素。我们从日本的五个机构招募了有 6 个月至 11 岁儿童的家长。我们进行了两次横断面在线调查和半结构化在线访谈。我们采用逻辑回归分析法探讨了与家长对子女接种疫苗犹豫不决有关的因素,并采用主题分析法对访谈数据进行了分析:结果:共有 134 名家长回复了这两项在线调查,其中 10 名家长参加了访谈。在第一次调查中,其子女对接种 COVID-19 疫苗的接受率为 19.4%(26/134),在第二次调查中,其子女对接种 COVID-19 疫苗的接受率为 11.2%(15/134)。整合数据后发现,疫苗接种犹豫不决的主要因素包括疫苗安全性、疫苗有效性、政府政策以及父母身边人的建议:结论:可随时获得的、更均衡的信息,以及来自父母身边的人和熟悉的医疗保健提供者的全社会支持,可能会为父母的决策提供更好的支持。如何以通俗易懂的方式提供信息还需要进一步研究。
{"title":"Perspectives on childhood coronavirus disease vaccination in Japan and influencing factors.","authors":"Madoka Lelliott, Masatsugu Sakata, Ayako Kohno, Rie Toyomoto, Ayuko Matsumoto, Toshi A Furukawa","doi":"10.1111/ped.15819","DOIUrl":"10.1111/ped.15819","url":null,"abstract":"<p><strong>Background: </strong>To support parental decision-making it is important to understand parents' perspectives on vaccination for their children and the factors that contribute to their vaccine hesitancy. There have been relatively few studies in this area in Japan, particularly with longitudinal and mixed methodologies.</p><p><strong>Methods: </strong>We used an explanatory sequential mixed methods approach to describe longitudinal changes in vaccine acceptance and to explore factors associated with parental coronavirus 2019 (COVID-19) vaccine hesitancy. We recruited parents who had children aged 6 months to 11 years old from five facilities in Japan. Two cross-sectional online surveys and semi-structured online interviews were conducted. Logistic regression analysis was used to explore factors associated with parents' vaccine hesitancy for their children, and thematic analysis was used to analyze the interview data.</p><p><strong>Results: </strong>In total, 134 parents responded to both online surveys and, of those, 10 participated in interviews. Acceptance rates of COVID-19 vaccination for their children were 19.4% (26/134) at the first survey and 11.2% (15/134) at the second survey. Integration of the data identified that the main factors for vaccine hesitancy included vaccine safety, vaccine effectiveness, government policy, and recommendations from people close to parents.</p><p><strong>Conclusions: </strong>Readily available and more balanced information, and community-wide support from people close to parents and familiar health-care providers are likely to provide better support for parents' decision-making. Further investigation is required on how to provide information in an easily understood manner.</p>","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":"66 1","pages":"e15819"},"PeriodicalIF":1.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11580370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142351961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic insights: Use of ceftazidime-avibactam in pediatric patients. 治疗见解:头孢他啶-阿维巴坦在儿科患者中的应用。
IF 1 4区 医学 Q3 PEDIATRICS Pub Date : 2024-01-01 DOI: 10.1111/ped.15787
Özge Metin Akcan, Mustafa Gençeli, Talha Üstüntaş, Abdullah Akkuş, Sevgi Pekcan, Metin Doğan

Background: The increasing worldwide prevalence of multidrug-resistant (MDR) bacteria underscores the pressing demand for innovative therapeutic solutions. Ceftazidime-avibactam (CAZ-AVI) represents a promising new drug combination that has received approval for specific infection types. However, there is limited information regarding its application in pediatric patients.

Methods: This study investigates the effectiveness and adverse reactions associated with CAZ-AVI treatment in pediatric patients with life-threatening infections caused by MDR pathogens. The study was conducted at a tertiary children's hospital between December, 2021 and July, 2023.

Results: A total of 21 patients with life-threatening infections caused by MDR pathogens were enrolled in the study. All patients had underlying medical conditions: 10 had cerebral palsy, four had congenital neurometabolic disease, two had Nieman-Pick disease, two had cystic fibrosis, two had primary immunodeficiency, and one had leukemia. Among these, 12 patients had tracheostomies. Eight patients received CAZ- AVI monotherapy, and 13 patients received combination therapy. Microbiological eradication was achieved in 18 patients (85.7%), and a clinical response was observed in 20 patients (95.2%). Two patients (9.5%) experienced relapse with the same bacteria. One patient developed anaphylaxis, and one patient had elevated creatine phosphokinase levels that normalized following discontinuation of treatment. One patient died during the study period due to gastrointestinal bleeding.

Conclusions: Ceftazidime-avibactam may be a promising new drug option for the treatment of life-threatening infections caused by MDR Gram-negative microorganisms in pediatric patients. However, further studies with larger case series are needed to further evaluate the efficacy and safety of CAZ-AVI in this population.

背景:耐多药(MDR)细菌在全球范围内的流行率不断上升,凸显了对创新治疗方案的迫切需求。头孢唑肟-阿维巴坦(CAZ-AVI)是一种前景看好的新药组合,已获准用于特定感染类型。然而,有关其在儿科患者中应用的信息却很有限:本研究调查了 CAZ-AVI 治疗由 MDR 病原体引起的危及生命的感染的儿科患者的有效性和相关不良反应。研究于 2021 年 12 月至 2023 年 7 月在一家三级儿童医院进行:共有21名MDR病原体引起的危及生命的感染患者参与了研究。所有患者都患有基础疾病:其中 10 人患有脑瘫,4 人患有先天性神经代谢疾病,2 人患有尼曼-皮克病,2 人患有囊性纤维化,2 人患有原发性免疫缺陷,1 人患有白血病。在这些患者中,有 12 人使用了气管造口术。8 名患者接受了 CAZ- AVI 单药治疗,13 名患者接受了联合治疗。18名患者(85.7%)实现了微生物根除,20名患者(95.2%)观察到了临床反应。两名患者(9.5%)复发了相同的细菌。一名患者出现过敏性休克,一名患者肌酸磷酸激酶水平升高,但在停止治疗后恢复正常。一名患者在研究期间因消化道出血而死亡:头孢唑肟-阿维巴坦可能是治疗儿童患者由革兰阴性耐药微生物引起的危及生命的感染的一种有前途的新药选择。然而,还需要进行更大规模的病例系列研究,以进一步评估 CAZ-AVI 在这一人群中的疗效和安全性。
{"title":"Therapeutic insights: Use of ceftazidime-avibactam in pediatric patients.","authors":"Özge Metin Akcan, Mustafa Gençeli, Talha Üstüntaş, Abdullah Akkuş, Sevgi Pekcan, Metin Doğan","doi":"10.1111/ped.15787","DOIUrl":"https://doi.org/10.1111/ped.15787","url":null,"abstract":"<p><strong>Background: </strong>The increasing worldwide prevalence of multidrug-resistant (MDR) bacteria underscores the pressing demand for innovative therapeutic solutions. Ceftazidime-avibactam (CAZ-AVI) represents a promising new drug combination that has received approval for specific infection types. However, there is limited information regarding its application in pediatric patients.</p><p><strong>Methods: </strong>This study investigates the effectiveness and adverse reactions associated with CAZ-AVI treatment in pediatric patients with life-threatening infections caused by MDR pathogens. The study was conducted at a tertiary children's hospital between December, 2021 and July, 2023.</p><p><strong>Results: </strong>A total of 21 patients with life-threatening infections caused by MDR pathogens were enrolled in the study. All patients had underlying medical conditions: 10 had cerebral palsy, four had congenital neurometabolic disease, two had Nieman-Pick disease, two had cystic fibrosis, two had primary immunodeficiency, and one had leukemia. Among these, 12 patients had tracheostomies. Eight patients received CAZ- AVI monotherapy, and 13 patients received combination therapy. Microbiological eradication was achieved in 18 patients (85.7%), and a clinical response was observed in 20 patients (95.2%). Two patients (9.5%) experienced relapse with the same bacteria. One patient developed anaphylaxis, and one patient had elevated creatine phosphokinase levels that normalized following discontinuation of treatment. One patient died during the study period due to gastrointestinal bleeding.</p><p><strong>Conclusions: </strong>Ceftazidime-avibactam may be a promising new drug option for the treatment of life-threatening infections caused by MDR Gram-negative microorganisms in pediatric patients. However, further studies with larger case series are needed to further evaluate the efficacy and safety of CAZ-AVI in this population.</p>","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":"66 1","pages":"e15787"},"PeriodicalIF":1.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141860589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid polymerase chain reaction-based diagnosis of yersiniosis causing recurrent intussusception. 基于聚合酶链反应的耶尔森氏菌病导致复发性肠套叠的快速诊断。
IF 1 4区 医学 Q3 PEDIATRICS Pub Date : 2024-01-01 DOI: 10.1111/ped.15757
Hiroto Mizushima, Hiroshi Uchida, Ryoichi Kitagata, Yusuke Isobe, Chiyoshi Toyama, Keigo Nara, Isao Miyairi
{"title":"Rapid polymerase chain reaction-based diagnosis of yersiniosis causing recurrent intussusception.","authors":"Hiroto Mizushima, Hiroshi Uchida, Ryoichi Kitagata, Yusuke Isobe, Chiyoshi Toyama, Keigo Nara, Isao Miyairi","doi":"10.1111/ped.15757","DOIUrl":"10.1111/ped.15757","url":null,"abstract":"","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":"66 1","pages":"e15757"},"PeriodicalIF":1.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141082045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Swimming was associated with rhinitis and pollinosis in a duration-dependent manner. 游泳与鼻炎和花粉症的关系与持续时间有关。
IF 1.4 4区 医学 Q3 PEDIATRICS Pub Date : 2024-01-01 DOI: 10.1111/ped.15758
Ayu Kawabata, Yuie Motoyama, Jiro Takeuchi, Takashi Kusunoki

Background: Previous studies have reported conflicting results regarding the effects of childhood swimming on respiratory allergic symptoms. We investigated the relationship between swimming and respiratory allergic symptoms in schoolchildren.

Methods: A questionnaire regarding participation in sports club activities and respiratory allergic symptoms in schoolchildren was distributed to the parents of all 6853 public school students (aged 6-14 years) in Omihachiman City, Shiga, Japan. The relationships between participation in sports club activities and the prevalence of respiratory allergic symptoms were analyzed by multivariable logistic regression analyses.

Results: Questionnaires were returned for 4991 schoolchildren (response rate: 72.8%). Logistic regression analysis revealed significant positive associations between swimming and rhinitis (42.9% vs. 38.9%; adjusted odds ratio, 1.26; 95% confidence interval, 1.10-1.44), and swimming and pollinosis (32.1% vs. 28.1%; adjusted odds ratio, 1.28; 95% confidence interval, 1.11-1.47). The duration of participation in swimming activities was also significantly positively associated with the prevalence of rhinitis and pollinosis. Those who had participated in swimming activities for 6 years or more showed significantly higher prevalences of rhinitis and pollinosis (46.3% and 36.4%, respectively) than those without swimming activities (38.9% and 28.1%, respectively) and those who had participated in swimming activities for 5 years or less (40.1% and 28.5%, respectively).

Conclusions: Swimming was associated with the prevalence of rhinitis and pollinosis in schoolchildren, especially among those who had participated in swimming activities for 6 years or more. Preventive measures and early interventions for rhinitis and pollinosis should be recommended to these children.

背景:以前的研究报告称,儿童游泳对呼吸道过敏症状的影响结果相互矛盾。我们调查了学龄儿童游泳与呼吸道过敏症状之间的关系:方法:我们向日本滋贺县近江八幡市所有 6853 名公立学校学生(6-14 岁)的家长发放了有关参加体育俱乐部活动和学龄儿童呼吸道过敏症状的调查问卷。通过多变量逻辑回归分析,分析了参加体育俱乐部活动与呼吸道过敏症状发生率之间的关系:结果:共收回 4991 份学童问卷(回收率:72.8%)。逻辑回归分析显示,游泳与鼻炎(42.9% 对 38.9%;调整后的几率比为 1.26;95% 置信区间为 1.10-1.44)和游泳与花粉症(32.1% 对 28.1%;调整后的几率比为 1.28;95% 置信区间为 1.11-1.47)之间存在明显的正相关关系。参加游泳活动的时间长短与鼻炎和花粉症的发病率也呈显著正相关。参加游泳活动 6 年或以上者的鼻炎和花粉症患病率(分别为 46.3% 和 36.4%)明显高于未参加游泳活动者(分别为 38.9% 和 28.1%)和参加游泳活动 5 年或以下者(分别为 40.1% 和 28.5%):结论:游泳与学龄儿童鼻炎和花粉症的发病率有关,尤其是在参加游泳活动 6 年或 6 年以上的学龄儿童中。应建议这些儿童采取鼻炎和花粉症的预防措施和早期干预措施。
{"title":"Swimming was associated with rhinitis and pollinosis in a duration-dependent manner.","authors":"Ayu Kawabata, Yuie Motoyama, Jiro Takeuchi, Takashi Kusunoki","doi":"10.1111/ped.15758","DOIUrl":"https://doi.org/10.1111/ped.15758","url":null,"abstract":"<p><strong>Background: </strong>Previous studies have reported conflicting results regarding the effects of childhood swimming on respiratory allergic symptoms. We investigated the relationship between swimming and respiratory allergic symptoms in schoolchildren.</p><p><strong>Methods: </strong>A questionnaire regarding participation in sports club activities and respiratory allergic symptoms in schoolchildren was distributed to the parents of all 6853 public school students (aged 6-14 years) in Omihachiman City, Shiga, Japan. The relationships between participation in sports club activities and the prevalence of respiratory allergic symptoms were analyzed by multivariable logistic regression analyses.</p><p><strong>Results: </strong>Questionnaires were returned for 4991 schoolchildren (response rate: 72.8%). Logistic regression analysis revealed significant positive associations between swimming and rhinitis (42.9% vs. 38.9%; adjusted odds ratio, 1.26; 95% confidence interval, 1.10-1.44), and swimming and pollinosis (32.1% vs. 28.1%; adjusted odds ratio, 1.28; 95% confidence interval, 1.11-1.47). The duration of participation in swimming activities was also significantly positively associated with the prevalence of rhinitis and pollinosis. Those who had participated in swimming activities for 6 years or more showed significantly higher prevalences of rhinitis and pollinosis (46.3% and 36.4%, respectively) than those without swimming activities (38.9% and 28.1%, respectively) and those who had participated in swimming activities for 5 years or less (40.1% and 28.5%, respectively).</p><p><strong>Conclusions: </strong>Swimming was associated with the prevalence of rhinitis and pollinosis in schoolchildren, especially among those who had participated in swimming activities for 6 years or more. Preventive measures and early interventions for rhinitis and pollinosis should be recommended to these children.</p>","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":"66 1","pages":"e15758"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141082048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Compound mutations in a patient with congenital long QT syndrome: Clinical challenges and genetic interpretation. 一名先天性长 QT 综合征患者的复合突变:临床挑战与基因解读。
IF 1 4区 医学 Q3 PEDIATRICS Pub Date : 2024-01-01 DOI: 10.1111/ped.15852
Hiroyuki Fukumoto, Yuji Ohnishi, Seigo Okada, Takahiro Motonaga, Takashi Furuta, Madoka Hoshide-Kajimoto, Shunji Hasegawa
{"title":"Compound mutations in a patient with congenital long QT syndrome: Clinical challenges and genetic interpretation.","authors":"Hiroyuki Fukumoto, Yuji Ohnishi, Seigo Okada, Takahiro Motonaga, Takashi Furuta, Madoka Hoshide-Kajimoto, Shunji Hasegawa","doi":"10.1111/ped.15852","DOIUrl":"https://doi.org/10.1111/ped.15852","url":null,"abstract":"","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":"66 1","pages":"e15852"},"PeriodicalIF":1.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to "Secular trends in longevity among people with down syndrome in Japan, 1995-2016". 更正 "1995-2016 年日本唐氏综合征患者的长寿趋势"。
IF 1 4区 医学 Q3 PEDIATRICS Pub Date : 2024-01-01 DOI: 10.1111/ped.15871
{"title":"Correction to \"Secular trends in longevity among people with down syndrome in Japan, 1995-2016\".","authors":"","doi":"10.1111/ped.15871","DOIUrl":"https://doi.org/10.1111/ped.15871","url":null,"abstract":"","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":"66 1","pages":"e15871"},"PeriodicalIF":1.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repeated management of a woman with ornithine transcarbamylase deficiency in two pregnancies. 对一名两次怀孕均患有鸟氨酸转氨酶缺乏症的妇女进行反复治疗。
IF 1 4区 医学 Q3 PEDIATRICS Pub Date : 2024-01-01 DOI: 10.1111/ped.15821
Tomo Suzuki, Aiko Sasaki, Nagayoshi Umehara, Yushi Ito, Reiko Horikawa, Haruhiko Sago
{"title":"Repeated management of a woman with ornithine transcarbamylase deficiency in two pregnancies.","authors":"Tomo Suzuki, Aiko Sasaki, Nagayoshi Umehara, Yushi Ito, Reiko Horikawa, Haruhiko Sago","doi":"10.1111/ped.15821","DOIUrl":"https://doi.org/10.1111/ped.15821","url":null,"abstract":"","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":"66 1","pages":"e15821"},"PeriodicalIF":1.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extensive giant umbilical cord as a potential risk of torsion. 巨大脐带是脐带扭转的潜在风险。
IF 1 4区 医学 Q3 PEDIATRICS Pub Date : 2024-01-01 DOI: 10.1111/ped.15812
Takao Kobayashi, Sota Iwatani, Ryo Nishimaki, Makiko Yoshida, Seiji Yoshimoto
{"title":"Extensive giant umbilical cord as a potential risk of torsion.","authors":"Takao Kobayashi, Sota Iwatani, Ryo Nishimaki, Makiko Yoshida, Seiji Yoshimoto","doi":"10.1111/ped.15812","DOIUrl":"https://doi.org/10.1111/ped.15812","url":null,"abstract":"","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":"66 1","pages":"e15812"},"PeriodicalIF":1.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142004956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiographic scores as a predictor of oxygenation index in very low-birthweight infants. 作为极低出生体重儿氧合指数预测指标的放射学评分。
IF 1 4区 医学 Q3 PEDIATRICS Pub Date : 2024-01-01 DOI: 10.1111/ped.15811
Masashi Zuiki, Kisho Asuka, Tomohiro Hasegawa, Madoka Uesugi, Rei Takada, Akio Yamano, Hidechika Morimoto, Kanae Hashiguchi, Tatsuji Hasegawa, Tomoko Iehara

Background: Very low birthweight infants (VLBWIs) often undergo chest radiographic examinations without standardization or objectivity. This study aimed to assess the association of two radiographic scores, the Brixia and radiographic assessment of lung edema (RALE), with oxygenation index (OI) in ventilated VLBWIs and to determine the optimal cutoff values to predict hypoxic respiratory severity.

Methods: VLBWIs who received invasive respiratory support with arterial lines between January 2010 and October 2023 were enrolled in this study (n = 144). The correlation between the Brixia or RALE scores and OI was investigated. Receiver operating characteristic curve analysis was performed to determine the optimal cutoff points of the two radiographic scores for predicting OI values (OI ≥5, ≥10, and ≥15).

Results: The enrolled infants had a median gestational age of 27 weeks (interquartile range [IQR], 25-28 weeks) and a median birthweight of 855 g (IQR, 684-1003 g). Radiographic scoring methods correlated with the OI (Brixia score: r = 0.79, p < 0.001; RALE score: r = 0.72, p < 0.001). The optimal cutoff points for predicting OI values were as follows: Brixia score: OI ≥5, 10; OI ≥10, 13; OI ≥15, 15; RALE score: OI ≥5, 22; OI ≥10, 31; and OI ≥15, 40.

Conclusions: Brixia and RALE scores are useful predictive markers of the oxygenation status in intubated VLBWIs with stable hemodynamics. These scores are easy to use and promising tools for clinicians to identify patients with a higher risk of hypoxic respiratory failure.

背景:超低出生体重儿(VLBWIs)通常会在没有标准化或客观性的情况下接受胸部放射成像检查。本研究旨在评估两种放射学评分(布里夏评分和肺水肿放射学评估(RALE))与通气的极低出生体重儿氧合指数(OI)之间的关联,并确定预测呼吸系统缺氧严重程度的最佳临界值:本研究招募了 2010 年 1 月至 2023 年 10 月期间接受动脉导管有创呼吸支持的低体重儿(n = 144)。研究调查了Brixia或RALE评分与OI之间的相关性。进行了接收者操作特征曲线分析,以确定预测 OI 值的两个放射学评分的最佳临界点(OI ≥5、≥10 和≥15):入组婴儿的中位胎龄为 27 周(四分位距[IQR]为 25-28 周),中位出生体重为 855 克(四分位距[IQR]为 684-1003 克)。放射学评分方法与 OI 存在相关性(Brixia 评分:r = 0.79,p 结论:OI 与 Brixia 评分存在相关性:Brixia 和 RALE 评分是预测插管低体重儿血流动力学稳定后氧合状态的有用指标。这些评分易于使用,是临床医生识别缺氧性呼吸衰竭风险较高患者的有效工具。
{"title":"Radiographic scores as a predictor of oxygenation index in very low-birthweight infants.","authors":"Masashi Zuiki, Kisho Asuka, Tomohiro Hasegawa, Madoka Uesugi, Rei Takada, Akio Yamano, Hidechika Morimoto, Kanae Hashiguchi, Tatsuji Hasegawa, Tomoko Iehara","doi":"10.1111/ped.15811","DOIUrl":"https://doi.org/10.1111/ped.15811","url":null,"abstract":"<p><strong>Background: </strong>Very low birthweight infants (VLBWIs) often undergo chest radiographic examinations without standardization or objectivity. This study aimed to assess the association of two radiographic scores, the Brixia and radiographic assessment of lung edema (RALE), with oxygenation index (OI) in ventilated VLBWIs and to determine the optimal cutoff values to predict hypoxic respiratory severity.</p><p><strong>Methods: </strong>VLBWIs who received invasive respiratory support with arterial lines between January 2010 and October 2023 were enrolled in this study (n = 144). The correlation between the Brixia or RALE scores and OI was investigated. Receiver operating characteristic curve analysis was performed to determine the optimal cutoff points of the two radiographic scores for predicting OI values (OI ≥5, ≥10, and ≥15).</p><p><strong>Results: </strong>The enrolled infants had a median gestational age of 27 weeks (interquartile range [IQR], 25-28 weeks) and a median birthweight of 855 g (IQR, 684-1003 g). Radiographic scoring methods correlated with the OI (Brixia score: r = 0.79, p < 0.001; RALE score: r = 0.72, p < 0.001). The optimal cutoff points for predicting OI values were as follows: Brixia score: OI ≥5, 10; OI ≥10, 13; OI ≥15, 15; RALE score: OI ≥5, 22; OI ≥10, 31; and OI ≥15, 40.</p><p><strong>Conclusions: </strong>Brixia and RALE scores are useful predictive markers of the oxygenation status in intubated VLBWIs with stable hemodynamics. These scores are easy to use and promising tools for clinicians to identify patients with a higher risk of hypoxic respiratory failure.</p>","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":"66 1","pages":"e15811"},"PeriodicalIF":1.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise leads to better sleep in children with inflammatory bowel disease. 运动能改善炎症性肠病患儿的睡眠。
IF 1 4区 医学 Q3 PEDIATRICS Pub Date : 2024-01-01 DOI: 10.1111/ped.15788
Ivana Trivić Mažuranić, Sara Sila, Zrinjka Mišak, Sanja Kolaček, Iva Hojsak

Background: The aim of our study was to investigate the effect of an exercise program on health-related quality of life (HRQoL) and sleep quality in children with inflammatory bowel disease (IBD) in remission.

Methods: A total of 42 pediatric IBD patients in remission were recruited to participate in a 6-month-long home-based exercise program. Their mean age was 15.3 years (with a range of ± 2.08 years) and there were 25 boys. With regard to disease type, 22 had Crohn's disease (CD), 18 had ulcerative colitis (UC), and two had unclassified inflammatory bowel disease (IBD-U). Prior to starting the program, and after its completion, HRQoL was assessed using the IMPACT III questionnaire, and sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) questionnaire. Patients also wore a triaxial accelerometer for 5 consecutive days before and after the completion of the exercise program to assess physical activity (PA) objectively.

Results: Study participants experienced no significant increase in their IMPACT III score (from 147.6 ± 2.7 to 149.6 ± 2.7, p = 0.106) following the completion of the exercise program. The prevalence of impaired sleep quality (PSQI > 5) decreased significantly from 30.9 to 23.8% (p = 0.027). At the baseline, participants' time spent in light PA (LPA) correlated positively with their IMPACT III score (coefficient (coef.) 0.398, p = 0.013). Following the completion of the resistance training program, the changes in the IMPACT III score correlated positively with time spent in moderate-to-vigorous PA (MVPA) (coef. 0.329, p = 0.047) and negatively with changes in PSQI score (coef. -0.493, p = 0.001).

Conclusion: The number of children with impaired sleep quality decreased significantly following the completion of a 6-month-long home-based resistance training program but improvements in HRQoL scores did not reach statistical significance.

研究背景我们的研究旨在调查运动项目对缓解期炎症性肠病(IBD)儿童健康相关生活质量(HRQoL)和睡眠质量的影响:共招募了 42 名处于缓解期的小儿 IBD 患者参加为期 6 个月的家庭锻炼计划。他们的平均年龄为 15.3 岁(± 2.08 岁不等),其中有 25 名男孩。就疾病类型而言,22 人患有克罗恩病(CD),18 人患有溃疡性结肠炎(UC),2 人患有未分类的炎症性肠病(IBD-U)。在计划开始前和完成后,使用 IMPACT III 问卷对患者的 HRQoL 进行了评估,并使用匹兹堡睡眠质量指数 (PSQI) 问卷对患者的睡眠质量进行了评估。患者还在运动计划完成前后连续 5 天佩戴三轴加速度计,以客观评估体力活动(PA):结果:在完成运动计划后,研究参与者的 IMPACT III 得分没有明显增加(从 147.6 ± 2.7 到 149.6 ± 2.7,p = 0.106)。睡眠质量受损(PSQI > 5)的比例从 30.9% 显著下降到 23.8%(p = 0.027)。在基线阶段,参与者的轻度活动时间(LPA)与他们的 IMPACT III 得分呈正相关(系数(coef.)阻力训练计划结束后,IMPACT III 分数的变化与中度至剧烈运动时间(MVPA)呈正相关(系数 0.329,p = 0.047),与 PSQI 分数的变化呈负相关(系数 -0.493,p = 0.001):结论:在完成为期 6 个月的家庭阻力训练项目后,睡眠质量受损的儿童人数明显减少,但 HRQoL 分数的改善未达到统计学意义。
{"title":"Exercise leads to better sleep in children with inflammatory bowel disease.","authors":"Ivana Trivić Mažuranić, Sara Sila, Zrinjka Mišak, Sanja Kolaček, Iva Hojsak","doi":"10.1111/ped.15788","DOIUrl":"https://doi.org/10.1111/ped.15788","url":null,"abstract":"<p><strong>Background: </strong>The aim of our study was to investigate the effect of an exercise program on health-related quality of life (HRQoL) and sleep quality in children with inflammatory bowel disease (IBD) in remission.</p><p><strong>Methods: </strong>A total of 42 pediatric IBD patients in remission were recruited to participate in a 6-month-long home-based exercise program. Their mean age was 15.3 years (with a range of ± 2.08 years) and there were 25 boys. With regard to disease type, 22 had Crohn's disease (CD), 18 had ulcerative colitis (UC), and two had unclassified inflammatory bowel disease (IBD-U). Prior to starting the program, and after its completion, HRQoL was assessed using the IMPACT III questionnaire, and sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) questionnaire. Patients also wore a triaxial accelerometer for 5 consecutive days before and after the completion of the exercise program to assess physical activity (PA) objectively.</p><p><strong>Results: </strong>Study participants experienced no significant increase in their IMPACT III score (from 147.6 ± 2.7 to 149.6 ± 2.7, p = 0.106) following the completion of the exercise program. The prevalence of impaired sleep quality (PSQI > 5) decreased significantly from 30.9 to 23.8% (p = 0.027). At the baseline, participants' time spent in light PA (LPA) correlated positively with their IMPACT III score (coefficient (coef.) 0.398, p = 0.013). Following the completion of the resistance training program, the changes in the IMPACT III score correlated positively with time spent in moderate-to-vigorous PA (MVPA) (coef. 0.329, p = 0.047) and negatively with changes in PSQI score (coef. -0.493, p = 0.001).</p><p><strong>Conclusion: </strong>The number of children with impaired sleep quality decreased significantly following the completion of a 6-month-long home-based resistance training program but improvements in HRQoL scores did not reach statistical significance.</p>","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":"66 1","pages":"e15788"},"PeriodicalIF":1.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatrics International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1